Patients with suspected bowel disease may soon have a faster route to diagnosis as they could refer themselves for scans, potentially bypassing long waiting lists and months of suffering with symptoms.
Currently, individuals with suspected inflammatory bowel disease (IBD) such as Crohn’s disease or ulcerative colitis have to first consult a GP before being referred for further investigation at a hospital. The process typically involves a faecal calprotectin test to detect inflammation-related proteins in the bowels. However, as inflammation can also be indicative of other conditions like food poisoning, patients often face additional delays as they are sent to specialists for further evaluation, potentially culminating in a colonoscopy.
Experts highlight that this prolonged process can be worrisome as delayed diagnosis in IBD cases can lead to increased risk of complications necessitating surgical interventions.
Recent research suggests that by offering patients two faecal tests spaced apart by approximately two weeks, the identification of IBD markers can be expedited, enabling direct referrals for colonoscopies. Dr. Peter Rimmer, a gastroenterologist at the University of Birmingham and the study’s author, envisions a future where patients could request these tests directly from the NHS without the need for a GP visit.
IBD affects around 800,000 individuals in the UK, with approximately 500,000 managing Crohn’s disease and nearly 300,000 dealing with ulcerative colitis. While these conditions are chronic and incurable, early detection and management through medications can significantly improve symptom control.
The study, involving 767 patients presenting IBD symptoms, demonstrated the efficacy of repeated faecal calprotectin tests preceding colonoscopies. Patients were also required to complete symptom questionnaires to rule out other potential health issues.
